Logo image of ATAI

ATAI BECKLEY NV (ATAI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ATAI - NL0015000DX5 - Common Stock

4.32 USD
-0.08 (-1.82%)
Last: 12/5/2025, 8:03:44 PM
4.2799 USD
-0.04 (-0.93%)
After Hours: 12/5/2025, 8:03:44 PM
Fundamental Rating

3

ATAI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 192 industry peers in the Pharmaceuticals industry. No worries on liquidiy or solvency for ATAI as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, ATAI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATAI had negative earnings in the past year.
In the past year ATAI has reported a negative cash flow from operations.
In the past 5 years ATAI always reported negative net income.
ATAI had a negative operating cash flow in each of the past 5 years.
ATAI Yearly Net Income VS EBIT VS OCF VS FCFATAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

ATAI has a worse Return On Assets (-78.89%) than 71.88% of its industry peers.
With a Return On Equity value of -103.85%, ATAI is not doing good in the industry: 63.02% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -78.89%
ROE -103.85%
ROIC N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ATAI Yearly ROA, ROE, ROICATAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ATAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATAI Yearly Profit, Operating, Gross MarginsATAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -20K -40K -60K

More info and screens

7

2. Health

2.1 Basic Checks

ATAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATAI has more shares outstanding
Compared to 5 years ago, ATAI has more shares outstanding
The debt/assets ratio for ATAI is higher compared to a year ago.
ATAI Yearly Shares OutstandingATAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ATAI Yearly Total Debt VS Total AssetsATAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 14.26 indicates that ATAI is not in any danger for bankruptcy at the moment.
ATAI has a Altman-Z score of 14.26. This is amongst the best in the industry. ATAI outperforms 84.90% of its industry peers.
ATAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 14.26
ROIC/WACCN/A
WACC7.44%
ATAI Yearly LT Debt VS Equity VS FCFATAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

ATAI has a Current Ratio of 4.02. This indicates that ATAI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ATAI (4.02) is comparable to the rest of the industry.
ATAI has a Quick Ratio of 4.02. This indicates that ATAI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ATAI (4.02) is better than 60.42% of its industry peers.
Industry RankSector Rank
Current Ratio 4.02
Quick Ratio 4.02
ATAI Yearly Current Assets VS Current LiabilitesATAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for ATAI have decreased by 0.00% in the last year.
The Revenue has decreased by -1.91% in the past year.
Measured over the past years, ATAI shows a very negative growth in Revenue. The Revenue has been decreasing by -75.28% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%

3.2 Future

The Earnings Per Share is expected to grow by 12.71% on average over the next years. This is quite good.
ATAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 226.91% yearly.
EPS Next Y45.22%
EPS Next 2Y23.88%
EPS Next 3Y13.75%
EPS Next 5Y12.71%
Revenue Next Year355.42%
Revenue Next 2Y-36.68%
Revenue Next 3Y18.97%
Revenue Next 5Y226.91%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ATAI Yearly Revenue VS EstimatesATAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
ATAI Yearly EPS VS EstimatesATAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATAI Price Earnings VS Forward Price EarningsATAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATAI Per share dataATAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as ATAI's earnings are expected to grow with 13.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.88%
EPS Next 3Y13.75%

More info and screens

0

5. Dividend

5.1 Amount

ATAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATAI BECKLEY NV

NASDAQ:ATAI (12/5/2025, 8:03:44 PM)

After market: 4.2799 -0.04 (-0.93%)

4.32

-0.08 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-16 2026-03-16/amc
Inst Owners13.93%
Inst Owner Change67.79%
Ins Owners2.66%
Ins Owner Change88.24%
Market Cap1.57B
Revenue(TTM)308.00K
Net Income(TTM)-149.27M
Analysts83.53
Price Target12.35 (185.88%)
Short Float %4.48%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.25%
Min EPS beat(2)-17.64%
Max EPS beat(2)17.15%
EPS beat(4)1
Avg EPS beat(4)-15.72%
Min EPS beat(4)-62.27%
Max EPS beat(4)17.15%
EPS beat(8)4
Avg EPS beat(8)10%
EPS beat(12)7
Avg EPS beat(12)5.89%
EPS beat(16)9
Avg EPS beat(16)-5.32%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.31%
PT rev (3m)7.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.93%
EPS NY rev (1m)-2.99%
EPS NY rev (3m)-6.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5094.09
P/FCF N/A
P/OCF N/A
P/B 10.92
P/tB 11.18
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0
BVpS0.4
TBVpS0.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -78.89%
ROE -103.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-52.42%
ROA(5y)-70.02%
ROE(3y)-67.79%
ROE(5y)-86.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 830.23%
Cap/Sales 2024.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.02
Quick Ratio 4.02
Altman-Z 14.26
F-Score2
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)268.35%
Cap/Depr(5y)673.01%
Cap/Sales(3y)220.74%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y45.22%
EPS Next 2Y23.88%
EPS Next 3Y13.75%
EPS Next 5Y12.71%
Revenue 1Y (TTM)-1.91%
Revenue growth 3Y-75.28%
Revenue growth 5YN/A
Sales Q2Q%1772.5%
Revenue Next Year355.42%
Revenue Next 2Y-36.68%
Revenue Next 3Y18.97%
Revenue Next 5Y226.91%
EBIT growth 1Y18.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.75%
EBIT Next 3Y-16.28%
EBIT Next 5Y-6.5%
FCF growth 1Y21.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.11%
OCF growth 3YN/A
OCF growth 5YN/A

ATAI BECKLEY NV / ATAI FAQ

What is the fundamental rating for ATAI stock?

ChartMill assigns a fundamental rating of 3 / 10 to ATAI.


What is the valuation status for ATAI stock?

ChartMill assigns a valuation rating of 0 / 10 to ATAI BECKLEY NV (ATAI). This can be considered as Overvalued.


What is the profitability of ATAI stock?

ATAI BECKLEY NV (ATAI) has a profitability rating of 0 / 10.


Can you provide the financial health for ATAI stock?

The financial health rating of ATAI BECKLEY NV (ATAI) is 7 / 10.